Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/21/08 → 3/22/19 |
Funding
- Quintiles Inc: $395,288.00
A Phase 3, Open-Label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease
- Flomenhoft, Deborah (PI)
- De Villiers, Willem (Former PI)